F18.188

Clinical Causes: Repeated inhalation of vapors from substances such as glue, paint thinner, aerosol sprays, refrigerants, or nitrous oxide. Psychological factors such asPeer influence, genetic predisposition, or underlying mental health conditions like depression or anxiety. Environmental factors including easy access to inhalants, social environment that encourages substance use, or peer pressure. Lack of awareness regarding the risks associated with inhalant use. Substance dependence developing over time due to repeated use.

Key Symptoms: Euphoria or feeling of being high shortly after inhalation. Dizziness, lightheadedness, or lack of coordination. Slurred speech and blurred vision. Nausea, vomiting, or headache. Difficulty concentrating or remembering recent events (mild neurocognitive impairment). Mood swings, irritability, or feelings of depression. Physical signs such as chemical odors on breath or clothing, chemical burns around the nose and mouth. Poor judgment, risky behaviors, or accidents resulting from impaired coordination.

Diagnosis Path: Diagnosis typically involves a comprehensive medical and psychological assessment. Healthcare providers may review the individual's medical history, conduct physical and neurological examinations, and evaluate behavioral patterns. Laboratory tests, such as blood or urine screenings, might detect substances related to inhalants. Neurocognitive assessments are utilized to evaluate any mild impairments in memory, problem-solving, and executive functioning. It's also important to rule out other causes of cognitive issues, such as neurological conditions or mental health disorders. Ultimately, the clinician must establish a pattern of inhalant use coinciding with neurocognitive symptoms to confirm the diagnosis.

Treatment Protocols: Treatment strategies focus on addressing both inhalant use disorder and any resulting cognitive or psychological issues. Approaches may include: - **Behavioral Therapy:** Cognitive-behavioral therapy (CBT) can help individuals recognize and modify patterns of inhalant use and develop coping strategies. - **Psychiatric Support:** Counseling or medication may be recommended for co-occurring mental health issues such as anxiety or depression. - **Support Groups:** Peer support groups provide a platform for shared experiences and encouragement throughout recovery. - **Monitoring and Follow-up:** Regular medical and neurocognitive evaluations to track progress and adjust treatment plans. - **Educational Programs:** Awareness campaigns to educate about the dangers of inhalant abuse. Rehabilitation programs may also be suggested for severe cases, emphasizing detoxification and long-term behavioral change.